Objective： To investigate the perioperative management of liver cancer patients with concomitant hyperglycemia undergoing hepatectomy.
Methods：The clinical data of 98 liver cancer patients with concomitant hyperglycemia were analyzed retrospetively.
Results：Of the 98 patients, the fasting blood glucose (BG) was controlled within 6.1-11.1 μmol/L, and ketonuria was negative before operation; intraoperation, the BG was controlled within 6.8-11.2 μmol/L; and the BG was controlled by insulin postoperatively. The 98 patients underwent operation uneventfully and all recovered. After operation,  surgical incision infection occurred in 7 cases (7.14%); pulmonary infection occurred in 3 cases (3.06%), among them 1 combined with ketoacidosis (1.02%);  urinary system infection occurred in 3 cases (3.06%) and abdominal abscess occurred in 1 case (1.02%).
Conclusions： Hepatic dysfunction of liver cancer patients may cause hyperglycemia or aggravate diabetes. For those with concomitant hyperglycemia, the perioperative management including tight blood glucose control, nutritional support enhancement, and aggressive treatment of complications such as infection and ketoacidosis is the important basis for successful surgical treament.